Quick Summary:
In an age where precision is the determining factor for success in the diagnostics and healthcare industry, having data-driven insights into the Molecular Quality Controls market is critical. With the global market estimated at US$214.9 Million, and projected to escalate to US$286.9 Million by 2030, understanding the underlying trends is paramount for informed decision-making.
Our comprehensive market research report provides in-depth analysis, exploring segments such as Independent Controls, projected to reach US$190.3 Million, and the Instrument-Specific Controls segment, undergoing readjustment to a revised 2.7% CAGR for the upcoming period. Detailed profiling of 33 featured competitors provides a competitive landscape allowing your business to understand how to better position itself within the market. The report includes geographic analysis of prominent regions, including the U.S. and China, amongst others. Harness the power of comprehensive data with our Molecular Quality Controls market report to stay ahead of the curve in this fast-evolving industry.
Global Molecular Quality Controls Market to Reach $286.9 Million by 2030
The global market for Molecular Quality Controls estimated at US$214.9 Million in the year 2022, is projected to reach a revised size of US$286.9 Million by 2030, growing at a CAGR of 3.7% over the analysis period 2022-2030. Independent Controls, one of the segments analyzed in the report, is projected to record 4.2% CAGR and reach US$190.3 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instrument-Specific Controls segment is readjusted to a revised 2.7% CAGR for the next 8-year period.
The U.S. Market is Estimated at $62.9 Million, While China is Forecast to Grow at 3.2% CAGR
The Molecular Quality Controls market in the U.S. is estimated at US$62.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$50 Million by the year 2030 trailing a CAGR of 3.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 2.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.Select Competitors (Total 33 Featured) -
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd
- Helena Biosciences Europe
- Maine Molecular Quality Controls, Inc.
- Microbiologics, Inc.
- Qnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- SeraCare Life Sciences, Inc.
- SERO AS
- Technopath Clinical Diagnostics
- Thermo Fisher Scientific Inc.
- ZeptoMetrix Corporation
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Molecular Quality Controls?
What is the growth rate of the Global Market for Molecular Quality Controls?
What is the forecasted size of the Global Market for Molecular Quality Controls?
Who are the key companies in the Global Market for Molecular Quality Controls?
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 214.9 Million |
| Forecasted Market Value ( USD | $ 286.9 Million |
| Compound Annual Growth Rate | 3.7% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- Danaher
- F. Hoffmann-La Roche Ltd
- Helena Biosciences Europe
- Maine Molecular Quality Controls, Inc.
- Microbiologics, Inc.
- Qnostics
- Quidel Corporation
- Randox Laboratories Ltd.
- SeraCare Life Sciences, Inc.
- SERO AS
- Technopath Clinical Diagnostics
- Thermo Fisher Scientific Inc.
- ZeptoMetrix Corporation
